SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 1)
MEDTECH DIAGNOSTICS, INC.
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, $0.00001 par value per share
- --------------------------------------------------------------------------------
(Title of Class of Securities)
585052103
- --------------------------------------------------------------------------------
(CUSIP Number)
Steven N. Bronson
16 East 52nd Street
Suite 501
New York, New York 10022
(212) 872-1623
with a copy to:
Steven D. Dreyer, Esq.
Hall Dickler Kent Friedman & Wood LLP
909 Third Avenue
New York, New York 10022
(212) 339-5580
- --------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)
September 24, 1998
- --------------------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
statement because of Rule 13d-1(b)(3) or (4), check the following box: |_|
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
<PAGE>
CUSIP No. 585052103 Page 2 of 4 Pages
- --------------------------------------------------------------------------------
1 Name of Reporting Person
S.S. or I.R.S. Identification No. of Above Person
Steven N. Bronson
- --------------------------------------------------------------------------------
2 Check the Appropriate Box If a Member of a Group*
a. |_|
b. |_|
- --------------------------------------------------------------------------------
3 SEC Use Only
- --------------------------------------------------------------------------------
4 Source of Funds*
PF
- --------------------------------------------------------------------------------
5 Check Box If Disclosure of Legal Proceedings Is Required Pursuant to
Items 2(d) or 2(e) |_|
- --------------------------------------------------------------------------------
6 Citizenship or Place of Organization
USA
- --------------------------------------------------------------------------------
7 Sole Voting Power
Number of
Shares 141,000,000
Beneficially --------------------------------------------------------------
Owned By 8 Shared Voting Power
Each
Reporting 0
Person --------------------------------------------------------------
With 9 Sole Dispositive Power
141,000,000
--------------------------------------------------------------
10 Shared Dispositive Power
0
- --------------------------------------------------------------------------------
11 Aggregate Amount Beneficially Owned by Each Reporting Person
141,000,000
- --------------------------------------------------------------------------------
12 Check Box If the Aggregate Amount in Row (11) Excludes Certain Shares* |_|
- --------------------------------------------------------------------------------
13 Percent of Class Represented By Amount in Row (11)
50.1%
- --------------------------------------------------------------------------------
14 Type of Reporting Person*
IN
- --------------------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
<PAGE>
Page 3 of 4 Pages
Except as expressly restated and amended below, the Schedule 13D,
dated June 5, 1996, as filed on behalf of Steven N. Bronson, with respect to the
shares of common stock, $.00001 par value (the "Common Stock") of Medtech
Diagnostics, Inc., a Delaware corporation ("Issuer"), remains in full force and
effect.
Item 2. Identity and Background
(a) This Amendment to Schedule 13D is being filed on behalf of
Steven N. Bronson.
(b) Mr. Bronson's business address is 16 East 52nd Street, Suite
301, New York, New York 10022.
(c) Mr. Bronson is President of Catalyst Financial Corp.
("Catalyst"), a broker-dealer registered under the Act.
(d) During the last five years Mr. Bronson has not been convicted in
a criminal proceeding (excluding traffic violations or similar misdemeanors).
(e) Mr. Bronson has not, during the last five years, been a party to
a civil proceeding of a judicial or administrative body of competent
jurisdiction, nor has Mr. Bronson been or is now or is subject to a judgment,
decree, or final order enjoining future violations of, or prohibiting or
mandating activities subject to federal or state securities laws or finding any
violation with respect to such laws.
(f) Mr. Bronson is a citizen of the United States of America.
Item 3. Source and Amount of Funds or Other Consideration
On September 24, 1998 Mr. Bronson, utilizing his personal funds,
acquired 70,500,000 shares of the Issuer's Common Stock from a principal
shareholder of the Issuer in a privately negotiated transaction for
consideration of $.00117 per share.
Item 5. Interest in Securities of the Issuer
(a)(b) Mr. Bronson may be deemed to beneficially own an aggregate of
141,000,000 shares of Common Stock, representing approximately 50.1% of the
total shares of Common Stock deemed outstanding. Mr. Bronson possesses sole
voting and dispositive power with respect to such shares of Common Stock.
The foregoing shares do not include any shares of Common Stock held
of record in the trading account of Catalyst.
<PAGE>
Page 4 of 4 Pages
(c) Not Applicable.
(d) No other person is known to have the right to receive or the
power to direct the receipt of dividends from, or the proceeds from the sale of,
such securities of the Issuer.
(e) Not Applicable.
After reasonable inquiry and to the best of my knowledge and belief,
I certify that the information as set forth in this statement is true, complete
and correct.
Date: December 28, 1998 /s/ STEVEN N. BRONSON
----------------------------
Steven N. Bronson
